On March 17, 2023, J-TEC obtained marketing approval for Autologous Cultured Epidermis Maintaining Melanocytes, a regenerative medical product for the treatment of vitiligo.
We are currently applying for insurance coverage.
Treatment for vitiligo with Autologous Cultured Epidermis
Autologous Cultured Epidermis Maintaining Melanocytes
Vitiligo is a disease in which there is a decrease or loss in the melanocytes that are normally distributed throughout the basement membrane of the skin for some reason, causing that area to appear white. There are a number of ways of treating this, but it is possible to aim for a color close to that of normal skin by culturing the patient's own skin and performing a transplant with "Autologous Cultured Epidermis" that is rich in melanocytes. This is a surgical procedure in which the affected skin is thinly shaved off and the Autologous Cultured Epidermis is applied over the area.
The use and commercialization of the medicinal products developed by Japan Tissue Engineering Co., Ltd. that are referred to on this website are approved only in Japan. A potential use and commercialization in other regions will be subject to the prior granting of a marketing authorization in the given territory and compliance with applicable laws.